Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.
A model of acute Legionella pneumophila pneumonia in neutropenic weanling rats was developed as a means of assessing the efficacies in vivo of the beta-lactams ticarcillin, ticarcillin-clavulanic acid, and clavulanic acid, agents active against the organism in vitro. Weanling rats were dosed with cyclophosphamide 3 days before and immediately prior to infection by intrabronchial intubation with L. pneumophila. The bacteria persisted in the lungs of untreated animals at high counts (5.0 to 7.0 log10 CFU/g of lung tissue) for up to 168 h after infection, and the histological characteristics of the infection were similar to those of the disease in humans. Transmission electron micrography revealed the presence of L. pneumophila multiplying within alveolar macrophages. Therapy with ticarcillin was ineffective in reducing the bacterial numbers in the lung tissue, whereas ticarcillin-clavulanic acid and clavulanic acid were active, producing bactericidal effects similar to those of erythromycin. The ticarcillin-clavulanic acid combination was significantly more efficacious (P less than 0.01) than corresponding doses of clavulanic acid alone. Synergistic activity between ticarcillin and clavulanic acid against L. pneumophila has been demonstrated in vivo, and the combination showed activity similar to that of erythromycin.
SmithKline Beecham Pharmaceuticals, Brockham Park, Betchworth, Surrey, England.
G M
GM
Smith
K H
KH
Abbott
M J
MJ
Wilkinson
A S
AS
Beale
R
R
Sutherland
D000818:Animals; D019818:Clavulanic Acid; D002969:Clavulanic Acids / Q000494:pharmacology*; D003520:Cyclophosphamide / Q000494:pharmacology; D007875:Legionella / Q000187:drug effects*; D007877:Legionnaires' Disease / Q000188:drug therapy* / Q000382:microbiology; D007958:Leukocyte Count; D008168:Lung / Q000382:microbiology; D008297:Male; D008854:Microscopy, Electron; D009503:Neutropenia / Q000150:complications / Q000276:immunology; D051381:Rats; D013982:Ticarcillin / Q000494:pharmacology*
D002969:Clavulanic Acids; D019818:Clavulanic Acid; D003520:Cyclophosphamide; D013982:Ticarcillin